Xenon Pharmaceuticals Inc.
Substituted benzamides and methods of use thereof
Last updated:
Abstract:
The invention provides compounds having the general formula I: ##STR00001## and pharmaceutically acceptable salts thereof, wherein the variables R.sup.A, R.sup.AA, subscript n, ring A, X.sup.2, L, subscript m, X.sup.1, ring B, R.sup.1, and R.sup.N have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.
Status:
Grant
Type:
Utility
Filling date:
3 Sep 2020
Issue date:
21 Dec 2021